Free Trial

Hyperfine Q4 2024 Earnings Report

Hyperfine logo
$0.72 -0.06 (-7.40%)
As of 03/28/2025 04:00 PM Eastern

Hyperfine EPS Results

Actual EPS
-$0.14
Consensus EPS
-$0.16
Beat/Miss
Beat by +$0.02
One Year Ago EPS
-$0.15

Hyperfine Revenue Results

Actual Revenue
$2.32 million
Expected Revenue
$2.30 million
Beat/Miss
Beat by +$21.00 thousand
YoY Revenue Growth
N/A

Hyperfine Announcement Details

Quarter
Q4 2024
Time
After Market Closes

Conference Call Resources

Remove Ads

Hyperfine Earnings Headlines

Lake Street Capital Begins Coverage on Hyperfine (NASDAQ:HYPR)
Warning: “DOGE Collapse” imminent
Elon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week, President Trump promised to buy a Tesla to help support Musk in the face of a boycott against his company. But according to one research group, with connections to the Pentagon and the U.S. government, Elon's preparing to strike back in a much bigger way in the days ahead.
Q1 Earnings Forecast for Hyperfine Issued By B. Riley
Hyperfine initiated with a Buy at Lake Street
B. Riley Cuts Hyperfine (NASDAQ:HYPR) Price Target to $1.20
See More Hyperfine Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Hyperfine? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Hyperfine and other key companies, straight to your email.

About Hyperfine

Hyperfine (NASDAQ:HYPR), a medical device company, provides magnetic resonance imaging (MRI) products in the United States. The company offers Swoop Portable MR imaging system, which offers portable brain neuroimaging; and support and technical assistance services. It serves ICU, comprehensive, and primary stroke accredited facilities through direct sales and distributors. Hyperfine, Inc. was founded in 2014 and is based in Guilford, Connecticut.

View Hyperfine Profile

More Earnings Resources from MarketBeat